Danielle Labbato and Grace A
Limitations and Remaining Questions While semaglutide has shown significant benefits in reducing joint pain among patients with obesity, several important limitations remain: Studies often lack post-treatment follow-up, making it unclear how durable these pain and weight outcomes are once medication is stopped
Users should consult healthcare providers, as self-administration carries risks of contamination, dosing errors, and regulatory violations
Warfarin and other coumarin anticoagulants : Monitor INR when initiating semaglutide in patients taking these medications
The brand highlights its plant-based, vegan, and cruelty-free approach, with minimalist packaging and a wellness-focused image that may appeal to ingredient-conscious shoppers
Recent research on the gut-kidney axis has revealed novel therapeutic pathways to alleviate inflammation, renal injury, and uremia, thereby preventing adverse clinical outcomes in CKD ( Figure 2 )